Premium
Nutraceuticals in Migraine: A Summary of Existing Guidelines for Use
Author(s) -
Rajapakse Thilinie,
Pringsheim Tamara
Publication year - 2016
Publication title -
headache: the journal of head and face pain
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.14
H-Index - 119
eISSN - 1526-4610
pISSN - 0017-8748
DOI - 10.1111/head.12789
Subject(s) - nutraceutical , migraine , medicine , coenzyme q10 , alternative medicine , polyunsaturated fatty acid , intensive care medicine , traditional medicine , psychiatry , biology , biochemistry , fatty acid , pathology , endocrinology
Background The use of nutraceuticals or food/herbal products for health benefits is expanding in adults with migraine as they seek relief from pain in an effective and tolerable manner not always afforded by current conventional pharmacologic therapies. Guidelines from the American Academy of Neurology/American Headache Society, Canadian Headache Society, and European Federation of Neurological Societies have discussed nutraceuticals in varying degrees of detail with at times conflicting recommendations. Conclusion This review serves to provide a summary of existing guidelines for the use of certain nutraceuticals including riboflavin, coenzyme Q10, magnesium, butterbur, feverfew, and omega‐3 polyunsaturated fatty acids. The review will also discuss the regulation of nutraceuticals in North America and the current controversy regarding butterbur and its safety.